ProQR Announces Virtual Presentation at EURETINA 2021 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. September 06, 2021
ProQR Announces Expert Perspectives Conference Call Series Press release Initial call in the series will feature Usher syndrome and retinitis pigmentosa on June 22 June 12, 2020
ProQR to Present at Upcoming Investor Conferences Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. November 13, 2019
ProQR Announces Extraordinary General Meeting of Shareholders Press release LEIDEN, the Netherlands, Dec. December 27, 2017
ProQR Announces Pricing of Initial Public Offering Press release LEIDEN, Netherlands, Sept. 18, 2014 (GLOBE NEWSWIRE) -- ProQR Therapeutics today announced the pricing of its initial public offering of 7,500,000 ordinary shares at an initial public offering price of $13.00 per ordinary share. September 18, 2014
ProQR to Present at Two Upcoming Conferences Press release LEIDEN, the Netherlands, April 03, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 03, 2018
ProQR to Participate in Upcoming Investor Conferences Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 03, 2020
ProQR Therapeutics Added to NASDAQ Biotechnology Index Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 24, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. December 24, 2018
Lilly and ProQR to Expand RNA Editing Collaboration Press release New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQR’s Axiomer technology December 22, 2022
ProQR Announces Proposed Public Offering of Ordinary Shares Press release LEIDEN, the Netherlands, Nov. November 13, 2017